Skip to main content
High RiskFDAfda-H-0422-2026OTHER

Hannaford hamburger dill pickle chips 16 FL OZ (1 PT) 473mL glass jar. UPC 0 41268 14889 9 DISTRIBUTED BY: HANNAFORD BROS. CO. SCARBOROUG...

Units Affected
2,484
Recall Date
January 7, 2026
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0422-2026.

Glass in Pickles. The firm received complaints of glass found in the product.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0422-2026.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Mount Olive Pickle Company, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0422-2026.

Mount Olive Pickle Company, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Mount Olive Pickle Company, Inc. Recall FAQ

Mount Olive Pickle Company, Inc. is the subject of a snacks & candy safety report: Hannaford hamburger dill pickle chips 16 FL OZ (1 PT) 473mL glass jar. UPC 0 41268 14889 9 DISTRIBUTED BY: HANNAFORD BROS. CO. SCARBOROUG.... The notice was published on January 7, 2026 by the U.S. Food and Drug Administration (FDA). Approximately 2,484 units are potentially affected.